Open Access

EDITORIAL

Vladimiro Vida^*
Congenital Heart Disease, Vol.17, No.1, pp. 1-3, 2022, DOI:10.32604/CHD.2022.019093 - 26 October 2021
Abstract This article has no abstract. More >

View

2355

Download

1691

Open Access

EDITORIAL

Shi-Joon Yoo^1,2,*, Sanga Lee³, Regina de la Mora⁴, Ankavipar Saprungruang², Christoph Haller⁵, Lee N. Benson², Vladimiro Vida⁶, Alvise Guariento⁶, Christopher Z. Lam¹
Congenital Heart Disease, Vol.17, No.1, pp. 5-23, 2022, DOI:10.32604/CHD.2022.018728 - 26 October 2021
Abstract Sinus venosus defects include two varieties, superior and inferior sinus venosus defects. The superior sinus venosus defect is characterized by abnormal communication between two closely related venoatrial structures: 1) the normally positioned superior vena cava-right atrium complex and 2) the right pulmonary vein-left atrium complex that is displaced leftward, forward and upward. Inferior sinus venosus defects primarily involve the inferior vena cava-right atrial junction while the right pulmonary vein-left atrial junction can also be affected. Because of the rarity and wide variation of the defects, the morphological characterization of sinus venosus defects is inconsistent among More >

View

2838

Download

2000

Open Access

CASE REPORT

Helena Staehler¹, Carina Hopfner², Masamichi Ono^1,*, Jürgen Hörer¹
Congenital Heart Disease, Vol.17, No.1, pp. 25-30, 2022, DOI:10.32604/CHD.2022.018366 - 26 October 2021
Abstract We report a very rare case of successful intracardiac correction in a patient with heterotaxy syndrome. The cardiac malformations included dextrocardia, double outlet right ventricle, pulmonary stenosis, interrupted inferior vena cava, hemiazygos continuation and total anomalous pulmonary venous return. One-stage correction was performed. The atrial procedure consisted of intra- and extraatrial rerouting of the anomalous systemic and pulmonary venous return. The hepatic veins were detached and diverted to the left atrium via an extracardiac conduit. The correction of the double outlet right ventricle was accomplished by intraventricular redirection of the blood flow from the left ventricle More >

View

2265

Download

1570

Like

1

Open Access

ARTICLE

Taiki Haga^1,*, Tomoyuki Masuyama², Yoshiro Hayashi³, Takahiro Atsumi⁴, Kenzo Ishii⁵, Shinsuke Fujiwara⁶
Congenital Heart Disease, Vol.17, No.1, pp. 31-43, 2022, DOI:10.32604/CHD.2022.017407 - 26 October 2021
Abstract Objectives: This study aimed to study the characteristics of in-hospital deterioration in patients with congenital heart disease who required rapid response system activation and identify risk factors associated with 1-month mortality. Methods: We retrospectively analysed data from a Japanese rapid response system registry with 35 participating hospitals. We included consecutive patients with congenital heart disease who required rapid response system activation between January 2014 and March 2018. Logistic regression analyses were performed to examine the associations between 1-month mortality and other patient-specific variables. Results: Among 9,607 patients for whom the rapid response system was activated, only 82… More >

View

3588

Download

2002

Open Access

REVIEW

Sibao Wang, Silin Pan^*, Gang Luo, Zhixian Ji, Na Liu
Congenital Heart Disease, Vol.17, No.1, pp. 45-60, 2022, DOI:10.32604/CHD.2022.016332 - 26 October 2021
Abstract The aim of this study was to perform a systematic review and meta-analysis to evaluate the safety and efficacy of ductus arteriosus stent (DAS) compared with surgical systemic-pulmonary artery shunt (SPS) in patients with ductal-dependent pulmonary blood flow. A literature search was conducted in PubMed, Embase, and the Cochrane Library databases from their inception to December 2020. Two reviewers independently screened the articles, evaluated the quality of the articles, and collected the data. Meta-analyses were conducted using fixed and random effects models. We used the I-square (I² ) test to examine heterogeneity and the funnel plot… More >

View

3020

Download

1898

Open Access

ARTICLE

Jianming Wang, Xianyang Zhu^*, Xiaotang Sheng, Jingsong Geng, Jiawang Xiao, Qiguang Wang^*
Congenital Heart Disease, Vol.17, No.1, pp. 61-70, 2022, DOI:10.32604/CHD.2022.017225 - 26 October 2021
Abstract Background: Left atrial appendage closure (LAAC) with simultaneous interventional occlusion therapy for congenital interatrial communication has become a new focus of patients with nonvalvular atrial fibrillation. Little is known about the results of mid-and long-term results. Objective: The aim of this study was to evaluate the midand long-term safety and effectiveness of simultaneous transcatheter closure of the left atrial appendage (LAA) and congenital interatrial communication closure in atrial fibrillation (AF) patients. Methods: From Jan 2016 to June 2017, 27 patients with AF were treated with simultaneous transcatheter closure of the LAA and atrial septal defect (ASD, n… More >

View

2735

Download

1692

Open Access

ARTICLE

Mina Tewfik^1,2,*, Maiy El-Sayed¹, Alaa Roushdy¹, Soha Romeih^2,3, Dina Ezzeldin¹, Hebatalla Attia¹
Congenital Heart Disease, Vol.17, No.1, pp. 71-85, 2022, DOI:10.32604/CHD.2022.018372 - 26 October 2021
Abstract Background: Bidirectional Glenn shunts have long been available as palliative procedures for patients with single ventricle physiology that is, patients unsuitable for biventricular repair. In our country they are performed at an older age than that recommended by the literature. So, we aim to assess post bidirectional Glenn shunt patients to detect the presence of any complications and to evaluate their functional capacity. Methods: This was a descriptive study that included all patients who underwent a bidirectional Glenn shunt and were referred for follow up in Ain shams university hospitals. History taking including NYHA class and… More >

View

3747

Download

2401

Like

3

Open Access

ARTICLE

Liping Wang, Mingjie Zhang, Xi Chen, Yachang Pang, Jiaqi Liu, Zhuoming Xu^*
Congenital Heart Disease, Vol.17, No.1, pp. 87-97, 2022, DOI:10.32604/CHD.2022.018452 - 26 October 2021
Abstract Background: Reversibility of pulmonary hypertension (PH) is closely related to the treatment options for and prognosis of children with congenital heart disease. Objective: We combined patient-specific clinical features including diagnosis, age and echocardiographic results, and biomarkers of pulmonary vascular dysfunction to explore the noninvasive methods that can be used to accurately evaluate the reversibility of pulmonary hypertension in congenital heart disease (PH-CHD). Methods: Based on the preoperative systolic pulmonary arterial pressure (sPAP), 70 CHD patients were divided into normal, PH-CHD suspected, and confirmed groups. Additionally, biomarkers of circulating endothelial cells (CECs), endothelin-1 (ET-1), and endothelial nitric oxide… More >

View

2339

Download

1548

Open Access

CASE REPORT

Yannick Kabulo Kolela^1,2, Maureen Klepper^1,2, Geoffroy de Beco^1,2, Thierry Sluysmans³, Alain Poncelet^1,2,*
Congenital Heart Disease, Vol.17, No.1, pp. 99-106, 2022, DOI:10.32604/CHD.2022.017635 - 26 October 2021
Abstract Arterial switch operation (ASO) is a complex neonatal operation in which transfer of the coronary arteries origins is the key to success. Coronary events after a successful ASO are not uncommon. We describe a rare case of a child who underwent an ASO in the neonatal period with one coronary (LAD) described as atretic left in place. At age seven, he developed myocardial ischemia due to retrograde flow with a steal phenomenon from the LAD into the pulmonary artery. The patient underwent a late LAD reimplantation. This case underscores that even very small ostia should More >

View

2549

Download

2077

Open Access

ARTICLE

Barry O’Callaghan¹, Jenny Zablah¹, Joseph Vettukattil², Daniel Levi^3,4, Morris Salem⁴, Allison Cabalka⁵, Jason Anderson⁶, Makram Ebeid⁶, Ryan Alexy⁷, Gareth J. Morgan^1,*
Congenital Heart Disease, Vol.17, No.1, pp. 107-116, 2022, DOI:10.32604/CHD.2022.018590 - 26 October 2021
Abstract Objectives: To detail the US multi-institutional experience with the Occlutech^© (Occlutech International AB, Helsingborg, Sweden) atrial flow regulator (AFR) in children and adults with acquired or congenital heart disease. Background: The creation of a long-term atrial communication is desirable in several cardiovascular disease phenotypes, most notably pulmonary arterial hypertension, disorders of increased left ventricular filling and increased cavopulmonary pressures in patients with a Fontan type circulation. Methods: Patients were identified for inclusion from the AFR device manufacturer database. Data was collected using a RedCap database following IRB approval. 8 weeks of follow up data was sought for… More >

View

2960

Download

1529